Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21736370 | 0.91 | PIM1 (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL21736269 | 0.88 | HRH4 (0.35) | HRH4HTR2CPIK3CA | |
| SCHEMBL21736271 | 0.86 | HRH4 (0.36) | HRH4HTR2CMAPTPIK3CA | |
| SCHEMBL21736295 | 0.86 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL20670196 | 0.85 | KDM4E (0.36) | KDM4EATML3MBTL1HRH4HTR2C | |
| SCHEMBL21736484 | 0.85 | HRH4 (0.33) | HRH4HTR2CPIK3CA | |
| SCHEMBL21736227 | 0.84 | KDM4E (0.32) | KDM4EATML3MBTL1HTR2C | |
| SCHEMBL21736004 | 0.83 | KDM4E (0.34) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL20669834 | 0.83 | PIK3CA (0.36) | KDM4EHRH4HTR2CALDH1A1LMNA | |
| SCHEMBL19247897 | 0.82 | ATM (0.40) | KDM4EATML3MBTL1HRH4HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | KDM4E 1417/4885ATM 3667/4885L3MBTL1 433/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | KDM4E 1417/4885ATM 3667/4885L3MBTL1 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.